New World cutaneous leishmaniasis imported into Australia.
A case of cutaneous leishmaniasis in a traveller from Belize, Central America is reported. Leishmaniasis presents rarely in Australia and delays in diagnosis and treatment often occur. A high index of suspicion in a patient who has returned from an endemic region is required. Subsequent confirmation of a diagnosis of cutaneous leishmaniasis is best achieved by demonstration of the organism on skin biopsy, aspiration or smear. The histology is variable and depends on geographic, parasite species and host factors. Speciation of New World disease as either Leishmania braziliensis or Leishmania mexicana is important to determine the risk of later development of mucosal disease, which normally only occurs with L. braziliensis infection, and for optimal treatment. Several different modes of treatment have been suggested, but antimonials, such as sodium stibogluconate, remain the treatment of choice in New World cutaneous leishmaniasis.
Maguire
G P
GP
Department of Infectious Diseases, Royal Darwin Hospital, Northern Territory, Australia.
Bastian
I
I
Arianayagam
S
S
Bryceson
A
A
Currie
B J
BJ
D000328:Adult; D000818:Animals; D001315:Australia; D004550:Elbow / Q000469:parasitology / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D007892:Leishmania braziliensis / Q000737:chemistry; D016773:Leishmaniasis, Cutaneous / Q000469:parasitology / Q000473:pathology*; D008297:Male; D012867:Skin / Q000469:parasitology / Q000473:pathology; D012871:Skin Diseases / Q000469:parasitology* / Q000473:pathology